Clinical Trial Update: Study to Check the Efficacy and Safety of Recombinant BCG Vaccine in Prevention of TB Recurrence [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 study evaluated the efficacy and safety of a recombinant BCG vaccine to prevent tuberculosis recurrence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Recombinant BCG Vaccine (Recombinant Bacillus Calmette-Guérin vaccine)

Snippet

Sponsor: Serum Institute of India Pvt. Ltd. | Conditions: Prevention of TB Recurrence | Phase 2, Phase 3 | Status: COMPLETED